Citations (7)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Fabiana de Sousa Cunha, Laise Nayra dos Santos Pereira, Thâmara Pryscilla de Costa e Silva, Roberto Alves de Sousa Luz & Anderson Nogueira Mendes. (2019) Development of nanoparticulate systems with action in breast and ovarian cancer: nanotheragnostics. Journal of Drug Targeting 27:7, pages 732-741.
Read now
Read now
Shardool Jain, Aatman S. Doshi, Arun K. Iyer & Mansoor M. Amiji. (2013) Multifunctional nanoparticles for targeting cancer and inflammatory diseases. Journal of Drug Targeting 21:10, pages 888-903.
Read now
Read now
Sara Zalba & María J Garrido. (2013) Liposomes, a promising strategy for clinical application of platinum derivatives. Expert Opinion on Drug Delivery 10:6, pages 829-844.
Read now
Read now
Articles from other publishers (4)
Lucy Wang, James C. Evans, Lubabah Ahmed & Christine Allen. (2023) Folate receptor targeted nanoparticles containing niraparib and doxorubicin as a potential candidate for the treatment of high grade serous ovarian cancer. Scientific Reports 13:1.
Crossref
Crossref
Krishna M. Gupta, Surajit Das, Pui Shan Chow & Calum Macbeath. (2020) Encapsulation of Ferulic Acid in Lipid Nanoparticles as Antioxidant for Skin: Mechanistic Understanding through Experiment and Molecular Simulation. ACS Applied Nano Materials 3:6, pages 5351-5361.
Crossref
Crossref
Reece G. Kenny & Celine J. Marmion. (2019) Toward Multi-Targeted Platinum and Ruthenium Drugs—A New Paradigm in Cancer Drug Treatment Regimens?. Chemical Reviews 119:2, pages 1058-1137.
Crossref
Crossref
René Raavé, Rob B.M. de Vries, Leon F. Massuger, Toin H. van Kuppevelt & Willeke F. Daamen. (2015) Drug delivery systems for ovarian cancer treatment: a systematic review and meta-analysis of animal studies. PeerJ 3, pages e1489.
Crossref
Crossref